Jones Financial Companies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9M Sell
141,894
-12,571
-8% -$4.3M 0.02% 405
2026
Q1
$53.9M Buy
154,465
+110,307
+250% +$39.3M 0.03% 323
2025
Q4
$14.5M Buy
44,158
+4,380
+11% +$1.39M 0.01% 384
2025
Q3
$10.9M Buy
39,778
+6,115
+18% +$1.77M 0.01% 389
2025
Q2
$9.33M Buy
33,663
+7,694
+30% +$2.18M 0.01% 367
2025
Q1
$7.98M Buy
25,969
+3,669
+16% +$1.08M 0.01% 343
2024
Q4
$5.81M Buy
22,300
+3,593
+19% +$1.07M 0.01% 337
2024
Q3
$6.04M Buy
18,707
+4,836
+35% +$1.58M 0.01% 269
2024
Q2
$4.33M Buy
13,871
+4,943
+55% +$1.45M 0.01% 222
2024
Q1
$2.54M Buy
8,928
+5,844
+189% +$1.71M ﹤0.01% 181
2023
Q4
$888K Buy
3,084
+1,171
+61% +$319K ﹤0.01% 205
2023
Q3
$514K Sell
1,913
-251
-12% -$62.6K ﹤0.01% 213
2023
Q2
$480K Sell
2,164
-387
-15% -$89.8K ﹤0.01% 218
2023
Q1
$617K Buy
2,551
+31
+1% +$7.61K ﹤0.01% 204
2022
Q4
$662K Buy
2,520
+258
+11% +$69.2K ﹤0.01% 199
2022
Q3
$510K Sell
2,262
-310
-12% -$75.1K ﹤0.01% 189
2022
Q2
$626K Sell
2,572
-23
-0.9% -$5.64K ﹤0.01% 178
2022
Q1
$628K Sell
2,595
-108
-4% -$24.8K ﹤0.01% 181
2021
Q4
$608K Buy
2,703
+203
+8% +$42.8K ﹤0.01% 174
2021
Q3
$532K Sell
2,500
-125
-5% -$28.8K ﹤0.01% 174
2021
Q2
$640K Sell
2,625
-321
-11% -$79K ﹤0.01% 166
2021
Q1
$733K Buy
2,946
+1,079
+58% +$257K ﹤0.01% 159
2020
Q4
$429K Buy
1,867
+1,012
+118% +$233K ﹤0.01% 175
2020
Q3
$218K Buy
+855
New +$212K ﹤0.01% 194
2020
Q1
Sell
-1,162
Closed -$280K 196
2019
Q4
$280K Buy
1,162
+108
+10% +$23.8K ﹤0.01% 192
2019
Q3
$204K Buy
+1,054
New +$202K ﹤0.01% 202
2019
Q1
Sell
-2,393
Closed -$466K 206
2018
Q4
$466K Buy
+2,393
New +$467K ﹤0.01% 169
2017
Q1
Sell
-1,636
Closed -$240K 222
2016
Q4
$240K Buy
1,636
+410
+33% +$61.7K ﹤0.01% 215
2016
Q3
$205K Sell
1,226
-193
-14% -$32.6K ﹤0.01% 216
2016
Q2
$216K Sell
1,419
-1,323
-48% -$206K ﹤0.01% 214
2016
Q1
$411K Buy
2,742
+934
+52% +$139K ﹤0.01% 178
2015
Q4
$293K Sell
1,808
-983
-35% -$155K ﹤0.01% 207
2015
Q3
$386K Buy
2,791
+183
+7% +$28.8K ﹤0.01% 197
2015
Q2
$400K Sell
2,608
-418
-14% -$67K ﹤0.01% 195
2015
Q1
$484K Sell
3,026
-443
-13% -$69.8K ﹤0.01% 187
2014
Q4
$553K Buy
3,469
+150
+5% +$23.4K ﹤0.01% 185
2014
Q3
$466K Buy
3,319
+493
+17% +$64.4K ﹤0.01% 187
2014
Q2
$335K Buy
2,826
+100
+4% +$11.6K ﹤0.01% 202
2014
Q1
$336K Sell
2,726
-225
-8% -$27.3K ﹤0.01% 196
2013
Q4
$337K Buy
2,951
+204
+7% +$23.2K ﹤0.01% 197
2013
Q3
$307K Buy
2,747
+86
+3% +$9.32K ﹤0.01% 193
2013
Q2
$263K Buy
+2,661
New +$276K ﹤0.01% 198

Other funds holding AMGN

Jones Financial Companies's AMGN Position: Q2 2026 in Review

Jones Financial Companies reduced its Amgen (AMGN) stake by 8.1% in Q2 2026, selling an estimated $4.3M and leaving 141,894 shares worth $50.9M. The position accounts for 0.02% of the portfolio, ranked #405.

Jones Financial Companies first reported a position in AMGN in Q2 2013 and has held it in 42 quarters since. The position peaked at $53.9M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Jones Financial Companies held 141,894 shares of Amgen worth $50.9M as of Q2 2026.
  • Jones Financial Companies sold 12,571 Amgen shares in Q2 2026, an estimated $4.3M.
  • Amgen made up 0.02% of Jones Financial Companies's portfolio in Q2 2026, its #405 holding.
  • Jones Financial Companies first reported a position in Amgen in Q2 2013 and has held it in 42 quarters since.
  • Jones Financial Companies's Amgen position peaked at $53.9M in Q1 2026.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.